                         SEQUENCE LISTING

<110>  University of Medicine and Dentistry of New Jersey
       Rutgers, The State University of New Jersey
       Bertino, Joseph R
       Banerjee, Debabrata
       Minko, Tamara
       Garbuzenko, Olga B
       Xie, Xiaoqi
       Kerrigan, John E
       Abali, Emine E
       Scotto, Kathleen W
 
<120>  E2F AS A TARGET FOR TREATMENT OF HORMONE REFRACTORY PROSTATE 
       CANCER

<130>  096738.00081

<140>  PCT/US10/031098
<141>  2010-04-14

<150>  US 61/212,699
<151>  2009-04-14

<160>  32    

<170>  PatentIn version 3.4

<210>  1
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide

<400>  1

His His His Arg Leu Ser His 
1               5           


<210>  2
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide

<400>  2

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  3
<211>  23
<212>  PRT
<213>  Artificial

<220>
<223>  experimental ;enetratin-peptide

<400>  3

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


His His His Arg Leu Ser His 
            20              


<210>  4
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(5)
<223>  Ser may be Cys or Gly

<400>  4

Thr Thr Thr Ser Ser Cys Gly Cys 
1               5               


<210>  5
<211>  25
<212>  DNA
<213>  Artificial

<220>
<223>  E2F sequence

<400>  5
atttaagttt cgcgcccttt ctcaa                                           25


<210>  6
<211>  25
<212>  DNA
<213>  Artificial

<220>
<223>  E2F sequence

<400>  6
ttgagaaagg gcgcgaaact taaat                                           25


<210>  7
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide

<400>  7

His Arg Pro Trp Ile Ala His 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide

<400>  8

His Ala Ile Tyr Pro Arg His 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  oligopeptide

<400>  9

Pro Glu Tyr Asp Pro Tyr Phe 
1               5           


<210>  10
<211>  49
<212>  PRT
<213>  Artificial

<220>
<223>  E2F1 protein fragment

<400>  10

Arg Phe Leu Glu Leu Leu Ser His Ser Ala Asp Gly Val Val Asp Leu 
1               5                   10                  15      


Asn Trp Ala Ala Glu Val Leu Lys Val Gln Lys Arg Arg Ile Tyr Asp 
            20                  25                  30          


Ile Thr Asn Val Leu Glu Gly Ile Gln Leu Ile Ala Lys Lys Ser Lys 
        35                  40                  45              


Asn 
    


<210>  11
<211>  49
<212>  PRT
<213>  Artificial

<220>
<223>  E2F2 protein fragment

<400>  11

Lys Phe Ile Tyr Leu Leu Ser Glu Ser Glu Asp Gly Val Leu Asp Leu 
1               5                   10                  15      


Asn Trp Ala Ala Glu Val Leu Asp Val Gln Lys Arg Arg Ile Tyr Asp 
            20                  25                  30          


Ile Thr Asn Val Leu Glu Gly Ile Gln Leu Ile Arg Lys Lys Ala Lys 
        35                  40                  45              


Asn 
    


<210>  12
<211>  49
<212>  PRT
<213>  Artificial

<220>
<223>  E2F3 protein fragment

<400>  12

Lys Phe Ile Gln Leu Leu Ser Gln Ser Pro Asp Gly Val Leu Asp Leu 
1               5                   10                  15      


Asn Lys Ala Ala Glu Val Leu Lys Val Gln Lys Arg Arg Ile Tyr Asp 
            20                  25                  30          


Ile Thr Asn Val Leu Glu Gly Ile His Leu Ile Lys Lys Lys Ser Lys 
        35                  40                  45              


Asn 
    


<210>  13
<211>  50
<212>  PRT
<213>  Artificial

<220>
<223>  E2F4 protein fragment

<400>  13

Lys Phe Val Ser Leu Leu Gln Glu Ala Lys Asp Gly Val Leu Asp Leu 
1               5                   10                  15      


Lys Leu Ala Ala Asp Thr Leu Ala Val Arg Gln Lys Arg Arg Ile Tyr 
            20                  25                  30          


Asp Ile Thr Asn Val Leu Glu Gly Ile Gly Leu Ile Glu Lys Lys Ser 
        35                  40                  45              


Lys Asn 
    50  


<210>  14
<211>  50
<212>  PRT
<213>  Artificial

<220>
<223>  E2F5 protein fragment

<400>  14

Lys Phe Val Ser Leu Leu Gln Glu Ala Lys Asp Gly Val Leu Asp Leu 
1               5                   10                  15      


Lys Ala Ala Ala Asp Thr Leu Ala Val Arg Gln Lys Arg Arg Ile Tyr 
            20                  25                  30          


Asp Ile Thr Asn Val Leu Glu Gly Ile Asp Leu Ile Glu Lys Lys Ser 
        35                  40                  45              


Lys Asn 
    50  


<210>  15
<211>  49
<212>  PRT
<213>  Artificial

<220>
<223>  E2F6 protein fragment

<400>  15

Lys Phe Met Asp Leu Val Arg Ser Ala Pro Gly Gly Ile Leu Asp Leu 
1               5                   10                  15      


Asn Lys Val Ala Thr Lys Leu Gly Val Arg Lys Arg Arg Val Tyr Asp 
            20                  25                  30          


Ile Thr Asn Val Leu Asp Gly Ile Asp Leu Val Glu Lys Lys Ser Lys 
        35                  40                  45              


Asn 
    


<210>  16
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  negative control sequence

<400>  16

Gly Gly Gly Ala Leu Ser Ala 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  negative control sequence

<400>  17

Ala Ala Ala Val Leu Ser Ala 
1               5           


<210>  18
<211>  23
<212>  PRT
<213>  Artificial

<220>
<223>  penetratin-linked peptide

<400>  18

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Gly Gly Gly Ala Leu Ser Ala 
            20              


<210>  19
<211>  23
<212>  PRT
<213>  Artificial

<220>
<223>  penetratin-linked peptide

<400>  19

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Ala Ala Ala Val Leu Ser Ala 
            20              


<210>  20
<211>  15
<212>  DNA
<213>  Artificial

<220>
<223>  oligonucleotide

<400>  20
agtttggcgc gaaat                                                      15


<210>  21
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  E2F-1 and DP1 peptide fragment


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is Ile or Val or conservative substitutions of Ile or Val

<400>  21

Arg Arg Xaa Tyr Asp 
1               5   


<210>  22
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  spacer peptide

<400>  22

Gly Gly Gly Ser 
1               


<210>  23
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  23
aggctggacc tggaaactga ccat                                            24


<210>  24
<211>  25
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  24
agctgcgtag tacagatatt catca                                           25


<210>  25
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  25
gcattaacct gcccactgtg ctgc                                            24


<210>  26
<211>  23
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  26
gtgccgagcc tcttggtata ggc                                             23


<210>  27
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  27
gcgctacagc ctgagagatg aatt                                            24


<210>  28
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  28
cttctgtcgt cagggttggt tttg                                            24


<210>  29
<211>  23
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  29
tggaggatga gccgctgctg aga                                             23


<210>  30
<211>  25
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  30
ttgacacaag gcatcgtttc aatgg                                           25


<210>  31
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  31
aggaaccgcc gccgttgttc ccgt                                            24


<210>  32
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  artificial primer

<400>  32
ctgcctgcaa agtcccggcc actt                                            24


